Subject Foundation from Beijing Department of Education
(XK100030514).
Notes and references
1 P. A. Ple, T. P. Green, L. F. Hennequin, J. Curwen, M. Fennell,
J. Allen, C. Lambertvan der Brempt and G. Costello, J. Med.
Chem., 2004, 47, 871.
2 (a) L. A. Doyle and D. D. Ross, Oncogene, 2003, 22, 7340;
(b) E. A. Henderson, V. Bavetsias, D. S. Theti, S. C. Wilson,
R. Clauss and A. L. Jackman, Bioorg. Med. Chem., 2006, 14, 5020.
3 (a) T.-C. Chien, C.-S. Chen, F.-H. Yu and J.-W. Chern, Chem.
Pharm. Bull., 2004, 52, 1422; (b) T. Herget, M. Freitag,
M. Morbitzer, R. Kupfer, T. Stamminger and M. Marschall,
Antimicrob. Agents Chemother., 2004, 48, 4154.
4 (a) K. Waisser, J. Gregor, H. Dostal, J. Kunes, L. Kubicova,
V. Klimesova and J. Kaustova, Farmaco, 2001, 56, 803;
(b) J. Kunes, J. Bazant, M. Pour, K. Waisser, M. Slosarek and
J. Janota, Farmaco, 2000, 55, 725.
5 (a) V. Colotta, D. Catarzi, F. Varano, O. Lenzi, G. Filacchioni,
C. Costagli, A. Galli, C. Ghelardini, N. Galeotti, P. Gratteri,
J. Sgrignani, F. Deflorian and S. Moro, J. Med. Chem., 2006, 49,
6015; (b) A. Lewerenz, S. Hentschel, Z. Vissiennon, S. Michael and
K. Nieber, Drug Dev. Res., 2003, 58, 420.
6 N. Malecki, P. Carato, G. Rigo, J. F. Goossens, R. Houssin,
C. Bailly and J. P. Henichart, Bioorg. Med. Chem., 2004, 12, 641.
7 (a) Z.-Z. Ma, Y. Hano, T. Nomura and Y.-J. Chen, Heterocycles,
1997, 46, 541; (b) S. Yoshida, T. Aoyagi, S. Harada, N. Matsuda,
T. Ikeda, H. Naganawa, M. Hamada and T. Takeuchi, J. Antibiot.,
1991, 44, 111; (c) Y. Deng, R. Xu and Y. Ye, J. Chin. Pharm. Sci.,
2000, 9, 116; (d) C. Wattanapiromsakul, P. I. Forster and
P. G. Waterman, Phytochemistry, 2003, 64, 609.
8 (a) A. Witt and J. Bergman, Curr. Org. Chem., 2003, 7, 659 and
references cited therein; (b) S. B. Mhaske and N. P. Argade,
Tetrahedron, 2006, 62, 9787 and references cited therein.
9 (a) D. J. Connolly, D. Cusack, T. P. O’Sullivan and P. J. Guiry,
Tetrahedron, 2005, 61, 10153; (b) Z. Ma, Y. Hano and T. Nomura,
Heterocycles, 2005, 65, 2203.
10 Selected examples, see: (a) K. R. Shreder, M. S. Wong,
T. Nomanbhoy, P. S. Leventhal and S. R. Fuller, Org. Lett.,
2004, 6, 3715; (b) M. Costa, N. D. Ca, B. Gabriele, C. Massera,
G. Salerno and M. Soliani, J. Org. Chem., 2004, 69, 2469;
(c) D. S. Yoon, Y. Han, T. M. Stark, J. C. Haber, B. T. Gregg
and S. B. Stankovich, Org. Lett., 2004, 6, 4775;
(d) S. H. Wiedemann, J. A. Ellman and R. G. Bergman, J. Org.
Chem., 2006, 71, 1969.
11 (a) A. Kamal, K. S. Reddy, B. R. Prasad, A. H. Babu and
A. V. Ramana, Tetrahedron Lett., 2004, 45, 6517;
(b) C. Larksarp and H. Alper, J. Org. Chem., 2000, 65, 2773.
12 (a) J.-F. Liu, P. Ye, B. Zhang, G. Bi, K. Sargent, L. Yu,
D. Yohannes and C. M. Baldino, J. Org. Chem., 2005, 70, 6339;
(b) J.-F. Liu, P. Ye, K. Sprague, K. Sargent, D. Yohannes,
C. M. Baldino, C. J. Wilson and S.-C. Ng, Org. Lett., 2005, 7, 3363.
13 For recent reviews on copper-catalyzed N-arylation, see:
(a) K. Kunz, U. Scholz and D. Ganzer, Synlett, 2003, 15, 2428;
(b) S. V. Ley and A. W. Thomas, Angew. Chem., Int. Ed., 2003, 42,
5400; (c) I. P. Beletskaya and A. V. Cheprakov, Coord. Chem. Rev.,
2004, 248, 2337; (d) G. Evano, N. Blanchard and M. Toumi, Chem.
Rev., 2008, 108, 3054.
14 (a) H. Rao, H. Fu, Y. Jiang and Y. Zhao, J. Org. Chem., 2005, 70,
8107; (b) H. Rao, Y. Jin, H. Fu, Y. Jiang and Y. Zhao, Chem.–Eur.
J., 2006, 12, 3636; (c) D. Jiang, H. Fu, Y. Jiang and Y. Zhao,
J. Org. Chem., 2007, 72, 672; (d) Q. Jiang, D. Jiang, Y. Jiang, H. Fu
and Y. Zhao, Synlett, 2007, 72, 1836; (e) X. Guo, H. Rao, H. Fu,
Y. Jiang and Y. Zhao, Adv. Synth. Catal., 2006, 348, 2197.
15 For recent studies on the synthesis of N-heterocycles through
Ullmann-type couplings, see: (a) A. Klapars, S. Parris,
K. W. Anderson and S. L. Buchwald, J. Am. Chem. Soc., 2004,
126, 3529; (b) B. Zou, Q. Yuan and D. Ma, Angew. Chem., Int. Ed.,
2007, 46, 2598.
Scheme 1 Plausible formation mechanism of quinazolinones.
We also attempted cascade reactions of substituted methyl
2-halobenzoates with amidine hydrochlorides to synthesize
various quinazolinone derivatives under our standard catalytic
conditions. As shown in Table 3, all the examined substrates
gave the corresponding quinazolines in good to excellent
yields. Interestingly, methyl 2-chlorobenzoate (4c) and methyl
2-bromobenzoate (4a) almost provided the same yields (com-
pare entries 1–3, 7–9), and methyl 2-chloronicotinate (4d) also
afforded the corresponding target products (5g,h) in good
yields (entries 10 and 11). In fact, aryl chlorides are weak
substrates in the previous copper-catalyzed N-arylations,13,14
and the results above could show an ortho-effect during
N-arylations (see reaction mechanism). Further, N-arylation
selectively occurred at the ortho-site of the ester group in
methyl 2-bromo-5-chlorobenzoate (4b) (entries 4–6). It is
worthwhile to note that reaction of electron-rich butyramidine
with methyl 2-bromobenzoate (4a) or methyl 2-chlorobenzoate
(4c) gave a minor quinozoline (6b) besides the major quina-
zolinone (5b) (entries 2 and 8). In addition, reactive activity of
amidines also showed similar results to Table 2.
Since the suitable ortho-substituents could promote
Ullmann-type couplings,16 a plausible formation mechanism
of quinazolinones was proposed in Scheme 1 according to the
results in Table 3. Coordination of L-proline with CuI in the
presence of base (Cs2CO3) first forms I (CuL). Substitution
reaction of methyl 2-halobenzoate with amidine hydrochloride
yields amide II in the presence of Cs2CO3, and treatment of II
with CuL (I) gives complex III, in which one nitrogen of the
amidine group may coordinate with the copper center to
provide additional stabilization. Oxidation addition of III
provides coordinate IV, and reduction elimination of IV
affords the target product 5 releasing the copper catalyst.
In summary, we have developed a general and highly
efficient method for synthesis of quinazoline and quinazoli-
none derivatives via copper-catalyzed cascade couplings of
amidine hydrochlorides with substituted 2-halobenzaldehydes,
2-halophenylketones and methyl 2-halobenzoates under mild
conditions. The present method shows simple, economical and
practical advantages over the previous methods, so it can
provide diverse molecules for organic chemistry and medicinal
chemistry.
This work was supported by the National Natural Science
Foundation of China (Grant No. 20672065), Chinese 863
Project (Grant No. 2007AA02Z160). Programs for New Cen-
tury Excellent Talents in University (NCET-05-0062) and
Changjiang Scholars and innovative Research Team in Uni-
versity (PCSIRT) (No. IRT0404) in China and the Key
16 (a) K. C. Nicolaou, C. N. C. Boddy, S. Natarajar, T.-Y. Yue,
H. Li, S. Brase and J. M. Ramanjulu, J. Am. Chem. Soc., 1997,
¨
119, 3421; (b) Q. Cai, B. Zou and D. Ma, Angew. Chem., Int. Ed.,
2006, 45, 1276.
ꢀc
This journal is The Royal Society of Chemistry 2008
Chem. Commun., 2008, 6333–6335 | 6335